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Conclusion. Systemic oxalosis in PH 1 children with ESRDPlasma calcium oxalate supersaturation in children with pri-
is due to higher POx and bCaOx levels. As bCaOx remained supersat-mary hyperoxaluria and end-stage renal failure.
urated in PH 1 even after aggressive HD, oxalate accumulationBackground. Children with primary hyperoxaluria type 1
increases, and CaOx tissue deposition occurs. Therefore, suffi-(PH 1) are at great risk to develop systemic oxalosis in end-
cient reduction of POx and bCaOx is crucial in PH 1 and mightstage renal disease (ESRD), as endogenous oxalate production
only be achieved by early, preemptive, combined liver-kidneyexceeds oxalate removal by dialytic therapy. As oxalate accu-
transplantation or liver transplantation alone.mulates, calcium oxalate (CaOx) tissue deposition occurs. Chil-
dren with other causes of ESRD, however, are not prone to
CaOx deposition despite elevated plasma oxalate (POx) levels.
Methods. Our study objective was to examine the potential Oxalate, an end product of metabolism, is normallymechanisms for these observations. We measured POx, sulfate, completely excreted by the kidneys. Because of endoge-citrate, and calculated CaOx saturation (bCaOx) in 7 children
nous oxalate overproduction in children with primarywith ESRD caused by PH 1 and in 33 children with non-
PH–related ESRD. Maintenance hemodialysis (HD) was per- hyperoxaluria (PH 1 and PH 2), the capacity of the
formed in 6 PH 1 and 22 non-PH patients: Pre- and post-HD kidneys to excrete the metabolic excess of oxalate is
levels were analyzed at this point and were repeated twice exceeded [1, 2]. Therefore, even in children with PH and
within 12 months in 5 PH 1 and 14 non-PH patients. Samples
normal renal function, both plasma oxalate (POx) andwere obtained only once in 12 patients (one PH 1) on peritoneal
plasma calcium oxalate (CaOx) saturation (bCaOx) weredialysis (PD). After liver-kidney or kidney transplantation,
found to be elevated [3]. Elevation in bCaOx is an impor-plasma levels were measured repetitively.
Results. The mean POx was higher in PH 1 (125.7 6 17.9 tant factor that produces systemic crystal deposition very
mmol/liter) than in non-PH patients (44.2 6 3.3 mmol/liter, P , early in the course of the disease [1–3].
1024). All other determined anions did not differ between the In end-stage renal disease (ESRD), oxalate accumula-two groups. bCaOx was higher in PH 1 (4.71 6 0.69 relative tion increases further, and patients with PH and ESRDunits) compared with non-PH children (1.56 6 0.12 units, P ,
are at great risk of developing progressive systemic ox-1024). POx and bCaOx were correlated in both the PH 1 (r 5 0.98,
P , 2 3 1024) and the non-PH group (r 5 0.98, P , 1024). alosis [4–6]. Despite a maximal oxalate elimination of 6
POx and bCaOx remained stable over time in the non-PH children, to 10 mmol/1.73 m2 per week by routine hemodialysis
whereas an insignificant decline was observed in PH 1 patients (HD) or peritoneal dialysis (PD) [7, 8], the oxalate bal-
after six months of more aggressive dialysis. bCaOx was supersat- ance remains positive. Thus, an ever increasing bodyurated (more than 1) in all PH 1 and in 25 out of 33 non-PH
oxalate burden further increases the likelihood of CaOxpatients. Post-HD bCaOx remained more than 1 in all PH 1, but
crystal deposition in tissue, bone, and retina [1, 7]. Chil-in only 2 out of 22 non-PH patients. In non-PH children, POx and
bCaOx decreased to normal within three weeks after successful dren with chronic renal insufficiency and ESRD but with-
kidney transplantation, whereas the levels still remained ele- out PH do not seem prone to CaOx depositions despite
vated seven months after combined liver-kidney transplanta- markedly elevated POx levels that exceed supersaturationtion in two PH 1 patients.
[2, 3, 7].
We hypothesized that bCaOx and its main determinant,
POx, would differ between the groups of children withKey words: crystal deposition, oxalosis, renal replacement therapy,
solid organ transplantation, liver. ESRD and provide evidence for the discrepancies in
CaOx metabolism. Therefore, we measured POx, citrateReceived for publication November 4, 1998
(PCit), and sulfate (PSulf) and calculated bCaOx in childrenand in revised form February 16, 1999
Accepted for publication February 16, 1999 with ESRD caused by either PH 1 or diseases unrelated
to PH. 1999 by the International Society of Nephrology
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Table 1. Clinical data in children with primary hyperoxaluria type 1
Duration Dialyzer-
Patient Age of RRT membrane size Blood flow Dialysis regimen CaOx
no. year Sex months m2 ml /min n/week 3 hr/session deposits Tx
1 0.9 M 12 Cobe 200/0.6 150 6 3 3–4 hr bones/retina LKTx
2 11.5 F 50 Fres. F50/1.1 240 3 3 4.5 hr bones/retina LKTx
3 8.5 M 16 Fres. F50/1.1 220 3 3 4.5/1 3 2 hr bones/retina deatha
4 1.5 F 2 Fres. F50/1.1 110 3 3 5 hr bones LTXb
5 0.7 F 1 Cobe 200/0.6 150 6 3 3 hr bones LKTx planned
6 8.5 F 6 CA 50/0.5 150 6 3 2 hr 1 CCPD bones LTxc
7 8.2 F 12 PD: — CCPD bones LKTx planned
Abbreviations are: LKTx, combined liver-kidney transplantaiton; LTx, liver transplantation; RRT, renal replacement therapy; CaOx, calcium oxalate; Fres.,
Fresenius; CA, Baxter; PD, peritoneal dialysis; CCPD, continuous cycler peritoneal dialysis.
a Patient 3 died due to systemic oxalosis before transplantation was possible
b Patient 4 first received a liver Tx due to his age and height; a kidney Tx is planned
c Patient 6 received a kidney Tx at another center, but diagnosis of PH was only made after recurrent oxalosis in the graft; patient 6 received a liver Tx, a kidney
Tx was planned, but the patient died of overwhelming infection
METHODS indicated in ESRD, but without special emphasis on
dietary oxalate content. Medication use was not con-Blood was analyzed in 40 children after informed con-
trolled in this study. Five of the seven PH 1 patientssent was obtained in the participating institutions. Seven
were on pyridoxine (50 to 100 mg/day). Radiographicwere diagnosed with ESRD caused by PH 1 (5 girls and
examinations to exclude oxalate osteopathy were per-2 boys aged 0.5 to 11.5 years; Table 1) and 33 children
formed in PH 1 patients, whereas available radiographswere diagnosed with non-PH–related ESRD (15 girls
in all non-PH patients, obtained for clinical reasons, wereand 18 boys, aged 2.0 to 20.5 years). Diseases in this latter
screened for the typical signs of CaOx deposition [10].group of children represented the spectrum of genetic,
Formal retinal examinations were performed in all PHstructural, and acquired diseases in which pediatric
1 patients for potential CaOx depositions, because inESRD is seen. The duration of renal failure requiring
systemic oxalosis, these deposits can be a sign of a moredialysis in the non-PH group ranged from 0.5 months
general deposition of CaOx in body tissue and bones [11].through 76 months (median, 16 months; mean, 16.5
One third of the non-PH patients had such examinations.months). Further clinical data in children with PH 1 are
Plasma samples were preserved, and specimens werein Table 1. PH 1 was diagnosed by the demonstration
shipped as previously described (all samples were ana-of elevated urinary oxalate and glycolate excretion prior
lyzed in Chicago, IL, USA) [12]. POx, citrate, sulfate,to ESRD and/or by partial deficiency or absence of the
and phosphate levels were measured by our described,liver-specific peroxisomal enzyme alanine:glyoxylate-
sequentional ion-chromatographic method [12]. Serumaminotransferase [9]. The study was approved by the
levels of total calcium, magnesium, sodium, potassium,Institutional Review Board of the Children’s Memorial
chloride, bicarbonate, and the free-flowing venous pHHospital in Chicago, Illinois, USA.
were measured in each participant’s blood sample by aMaintenance bicarbonate-based HD was performed
routine lab procedure [13].routinely in 6 PH 1 and in 22 non-PH children; chronic
As previously described, a personal computer-basedPD (automated or manual exchanges) was used as renal
program for solution equilibria was used for the calcula-replacement therapy (RRT) in one PH 1 patient and in
tion of bCaOx [4, 12]. The total concentration (mmol/liter)11 non-PH children. Table 1 contains the dialytic regi-
of each analyte and a constant for ammonium (NH4 5men employed for the PH 1 children.
0.01) were entered into this program. The saturationPlasma levels of oxalate were measured before HD
index was defined as the product of the calculated freein 19 non-PH and two PH 1 patients, and were repeated
calcium and oxalate concentrations, divided by the abso-twice more (pre- and post-HD) over an additional 12
lute solubility product for CaOx at the actual ionicmonths in 14 non-PH and five PH 1 children. Predialysis
strength of the plasma sample [4, 14].and postdialysis levels of POx were measured once in
Plasma anion levels are expressed in mmol/liter (se)PD patients, as POx levels do not fluctuate after each
for oxalate and citrate and in mmol/liter (se) for all otherindividual exchange in PD (data not reported). Addition-
parameters. bCaOx is expressed in relative units (se). bCaOxally, we made multiple measurements of POx after suc-
cessful renal transplantation in eight non-PH patients levels above one denote CaOx supersaturation [3, 4, 14].
The Mann–Whitney rank sum test was used for analysesand after successful combined liver-kidney transplanta-
tion in two PH 1 patients. of the two groups (PH 1 and non-PH children). Simple
correlation analysis was performed by least-square linearDietary and fluid intakes were restricted as clinically
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Table 2A. Plasma anion levels and calculated calcium-oxalate saturation (bCaOx) in children with end-stage renal disease (ESRD)
Oxalate Citrate Sulfate Phosphate
bCaOx
N lmol/liter mmol/liter relative units
PH 1 7 125.7 (17.9)a 100.4 (9.99) 0.99 (0.15) 1.31 (0.11) 4.71 (0.69)a
Non-PH 33 44.2 (3.3) 91.8 (8.2) 1.03 (0.11) 1.63 (0.14) 1.56 (0.12)
In HD patients, blood was obtained pre-dialysis. Values are mean (se).
a P , 0.001 PH 1 vs. non-PH
Table 2B. Serum concentrations of parameters used to calculate bCaOx
Ca Mg Na K Cl CO2
pHmmol/liter
PH 1 N 5 7 2.31 (0.05) 0.97 (0.07) 139.4 (1.2) 4.7 (0.36) 99.6 (2.2) 23.1 (2.6) 7.36 (0.02)
Non-PH N 5 33 2.45 (0.03) 0.92 (0.03) 139.7 (0.5) 4.9 (0.18) 103.5 (0.9) 23.0 (0.8) 7.36 (0.01)
Values are mean (se). Serum concentrations of relevant parameters were entered in the personal computer based program for solution equilibria to calculate bCaOx.
regression and was confirmed by stepwise linear regres- patients with or without PH and are similar to levels
observed in children with chronic renal insufficiencysion between all plasma anion concentrations and the
bCaOx and between the serum bicarbonate concentration, (CRI) who have bCaOx supersaturation [3].
Measurements in the HD population were performedthe venous pH, and the anion levels, respectively. All
statistical analyses were performed on a personal com- twice more in the ensuing 12 months at a frequency of
every four to six months. POx and bCaOx levels were foundputer (SigmaStat, SPSS Inc., Chicago, IL, USA). P values
less than 0.05 were considered significant. to remain stable, but elevated, in the non-PH patients
(Fig. 2). A slight decline of POx and bCaOx in PH patients,
however, was achieved by an increase in dialysis prescrip-
RESULTS tion in three children, whose initial POx values were ex-
When compared with our previously established nor- tremely high (149 to 178.5 mmol/liter). Thereafter, both
mal values in healthy infants and children [12], the mean POx and bCaOx remained stable in the PH 1 group and
anion concentrations and the bCaOx levels were elevated significantly higher than in the non-PH patients (P ,
in all children examined in this study (P , 1024), except 0.01) at any time point.
for citrate, which was not significantly different from bCaOx was significantly correlated to POx in both PH 1
normal. POx, PSulf, and bCaOx were significantly elevated in (r 5 0.98, P , 2 3 1024) and non-PH children (r 5 0.98,
ESRD when compared with patients with chronic renal P , 1024). In non-PH children, bCaOx was correlated with
insufficiency or to PH 1 patients with normal renal func- PSulf (r 5 0.45, P , 0.01). No significant correlations were
tion, as reported previously (P , 1024 for POx and bCaOx; noted between bCaOx and SCa, PCit, or PPhos. There were no
P , 0.02 for PSulf) [3]. significant differences within each group of children in
In ESRD, the mean POx was 2.8-fold higher in PH 1 Pox or bCaOx based on modality of dialysis.
patients when compared with the non-PH children (P , Mean sulfate, citrate, and phosphate levels were not
1024; Table 2A). The POx was lower in 31 out of 33 non- different between PH 1 and non-PH patients nor were
PH children when compared with the PH 1 children with the other parameters included in the equilibrium pro-
ESRD (Figs. 1 and 2). gram, which calculated bCaOx (Table 2B).
The mean bCaOx was threefold higher in PH 1 than in Mild metabolic acidosis was observed in 11 patients
non-PH children (P , 1024; Figs. 1 and 2 and Table 2A). (3 PH 1) and was actively treated. Acidosis, however,
Plasma was supersaturated in each of the PH 1 children did not influence bCaOx. This is probably best expressed
both before and after HD treatment. bCaOx was elevated by a lack of correlation between PCit and bicarbonate (r 5
above normal in all children with ESRD unrelated to 0.28, P 5 NS) and the venous pH (r 5 0.19, P 5 NS)
hyperoxaluria prior to the HD procedure and was super- in those patients with acidosis.
saturated in 25 out of 33 non-PH children (16 out of 22 All PH patients had signs of systemic oxalosis. Oxalate
HD patients) at that time point. bCaOx supersaturation osteopathy was diagnosed in all patients (and judged as
remained in only two non-PH patients after routine HD severe in three), and three patients had retinal CaOx
(post-HD bCaOx 5 1.05 and 1.08 relative units, respec- deposition. However, no signs of systemic oxalosis (bone
tively, in those two patients; Fig. 1). POx levels above 30 or retinal CaOx depositions) were found in the non-PH
children with ESRD.mmol/liter were predictive of bCaOx supersaturation in
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Fig. 1. Prehemodialysis and posthemodialysis levels of plasma oxalate (POx; A) and calculated calcium oxalate saturation (bCaOx; B) in primary
hyperoxaluria type 1 (PH 1; N 5 6) and non-PH (N 5 22) patients. Box plots depict mean (heavy line), median (thin line), 25% and 75% quartile
values (end of box), and 5th and 95th percentile values (error bars). Outliers are marked (s).
Fig. 2. Plasma oxalate (POx; A) and calculated calcium oxalate saturation (bCaOx; B) prehemodialysis levels over 12 months in primary hyperoxaluria
type 1 (PH 1; N 5 6) and non-PH 1 patients (N 5 22) on hemodialysis. I, initial values; II, after 4 to 6 months; III, after 10 to 12 months. Box
plots depict mean (heavy line), median (thin line), 25% and 75% quartile values (end of box), and 5th and 95th percentile values (error bars).
Outliers are marked (s).
During the period of this study, 11 kidneys were trans- DISCUSSION
planted in non-PH patients. POx and bCaOx rapidly de- Children with ESRD have significant elevation of POx
creased in all patients with a functioning graft within levels and bCaOx when compared with healthy children
two to three weeks (representative studies; Fig. 3). Two and children with CRI [3, 12]. However, both of these
PH 1 patients received a combined liver-kidney trans- parameters were significantly higher in children with PH 1
plant. Their POx and bCaOx values, although decreasing compared to non-PH children in ESRD. Prior to a regu-
substantially after successful transplantation, neverthe- lar HD or PD treatment, bCaOx supersaturation was found
less remained elevated even at 240 days post-transplanta- in all PH 1 and in 25 out of 33 of the non-PH children.
Thus, we can support our hypothesis that POx and bCaOxtion (representative study; Fig. 4).
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Fig. 3. POx levels (s) and bCaOx (d) in two non-PH patients: a three-year-old boy with obstructive uropathy (A) and a 16-year-old boy with renal
dysplasia (B) before and after successful kidney transplantation. For reference, normal levels of oxalate are 6.4 6 0.15 [12].
Fig. 4. POx levels (s) and bCaOx (d) in a pa-
tient with primary hyperoxaluria (patient 1;
Table 1) after successful, combined liver-
kidney transplantation. The hatched area rep-
resents the levels of oxalate in normal chil-
dren.
supersaturation differ substantially as an explanation for after transplantation in non-PH children, which suggests
that the body oxalate burden is low in these children.systemic oxalosis in PH patients with ESRD.
Although POx levels and bCaOx may be elevated in both CaOx crystal depositions were found in only the PH 1
patients. Moreover, POx levels and bCaOx in PH 1 childrenpopulations prior to the performance of dialysis and
higher in PH 1 than in non-PH children, the return to were still elevated up to seven months after successful
combined liver-kidney transplantation, leading us toundersaturation (bCaOx , 1) after dialysis was observed
in the overwhelming majority of the non-PH children speculate that a high body oxalate burden accounts for
the persistent supersaturation. As one limitation to ourbut in none with PH. Such reduction of bCaOx supersatura-
tion in the non-PH children might be protective from study, we note that we did not measure the expected
“rebound” of POx levels after the HD procedure. ThereCaOx crystal deposition disease. This assumption is con-
firmed further, as POx levels and bCaOx declined rapidly may or may not be differences in the rate of rebound
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between the two groups of patients studied. However, during PD has not been seen previously in such patients.
Therefore, unknown, but presumably protective factorssuch differences, if present, did not produce clinical sys-
might help prevent the risk of systemic oxalosis in thesetemic oxalosis in the non-PH patients that we studied.
children, as we have speculated previously to be presentOur findings that POx levels are elevated in ESRD
in children with CRI [12], despite CaOx supersaturation.patients and bCaOx is supersaturated in PH 1 and in a high
Because there is an excellent correlation of POx and bproportion of the non-PH children are in accordance
in children with normal renal function, in children withwith the general observations in adult patients with
modest renal insufficiency with or without PH 1 [3], andESRD [5, 14, 15]. The persistent nature of bCaOx supersat-
now in children with ESRD, we suggest that POx aloneuration despite iterative dialysis has been reported in a
likely suffices for clinical purposes of determining thelimited number of adults with PH 1 on maintenance
risk of systemic oxalosis. Both in our previous work [3]HD [14, 15]. We are unaware of previous reports of
and in the current study, a POx level of 30 mmol/liter orthe change in these parameters after successful organ
more is associated with a b . 1.transplantation in patients with PH.
In this study, we observed that a routine or even mod-Previous studies, including one of our own, demon-
erately aggressive HD prescription was not sufficientstrated that oxalate removal by the usual prescription of
to ameliorate persistent bCaOx supersaturation in PH 1dialysis chosen for RRT is unable to prevent elevation
patients. Therefore, even more aggressive HD prescrip-of POx and is even more markedly elevated in PH 1
tions, combined perhaps with additional PD treatments,children and adults who have increased endogenous oxa-
may be necessary to reduce the risk of systemic oxalosislate production [7, 8]. We did not observe a significant
in children with PH. We speculate, however, that early,change in POx levels and bCaOx over the observation period
probably preemptive, liver transplantation might bein each of the PH 1 patients in this report, despite an
more crucial for children with PH than anticipated cur-increase in the dialytic prescription, which suggested that
rently, given the difficulty in achieving lowered POx levelsthe excessive endogenous oxalate produced in PH 1 re-
through dialytic therapies. The optimal time for preemp-sulted in an accumulation in body stores such as bone
tive transplantation in PH 1 to prevent systemic oxalosisand tissue rather than solely in the plasma fraction. This
remains unknown. Cochat and Schaerer proposed thatis further substantiated by the finding of clinical signs of
renal functional deterioration be the time post for trans-systemic oxalosis in all PH 1 patients, including severe
plantation and suggested transplantation when the glo-oxalate osteopathy in three.
merular filtration rate is still above 40 ml/min/1.73 m2The sequential measurements of POx levels and bCaOx [18]. Therefore, based on this demonstration of persis-after transplantation were instructive as to the severity of
tent supersaturation of plasma CaOx at ESRD and ourPH 1. Although liver-kidney transplants were functioning
earlier demonstration of supersaturation in children withnormally in the PH 1 patients and the hepatic production
PH 1 and normal renal function [12], preemptive liver
rate of oxalate was therefore presumed to be normal, transplantation might have a key role much earlier in
POx levels and bCaOx were still elevated for more than six the course of the disease, as recently demonstrated in a
months after transplantation, indicating that the body brief case report [19]. The seemingly higher mortality of
oxalate burden was extremely high. Bone oxalate con- liver or liver-kidney transplantation in this disease, when
tent ranging from 14.8 to 907 mmol Ox/g bone was dem- compared with non-PH diseases, lends caution to any
onstrated in adult PH 1 ESRD patients compared with recommendation for transplantation, however [20]. A
5.1 6 3.6 mmol Ox/g bone in non-PH ESRD patients multicenter study of hyperoxaluria seems warranted to
[16]. On the other hand, POx levels and bCaOx were within best define optimal therapies for all patients with persis-
the normal range after three weeks in all of the non-PH tent supersaturation in ESRD.
children with a functioning kidney graft. This is compara-
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